XML 41 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies (Details Narrative) (USD $)
2 Months Ended 12 Months Ended
Dec. 08, 2014
Sep. 30, 2014
Sep. 30, 2013
Revenue   $ 12,262,198us-gaap_Revenues $ 15,641,062us-gaap_Revenues
Cash deposits in excess of FDIC limit   10,572,702us-gaap_CashUninsuredAmount 3,128,187us-gaap_CashUninsuredAmount
Note receivable, monthly amount   15,000us-gaap_AccountsNotesAndLoansReceivableNetCurrent  
Note receivable interest rate   17.00%us-gaap_TimeSharingTransactionsStatedInterestRatesForNotesReceivableMinimum  
Accrued interest, note receivable   156,323us-gaap_AllowanceForNotesAndLoansReceivableCurrent 15,211us-gaap_AllowanceForNotesAndLoansReceivableCurrent
Impairment of inventory   153,633us-gaap_InventoryWriteDown 211,555us-gaap_InventoryWriteDown
Impairment expense for future impairmant of monitoring equipment   220,318us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense  
Impaired Assets to be Disposed of by Method Other than Sale, Amount of Impairment Loss   3,710us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss 4,740us-gaap_ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss
Depreciation Expense   276,355us-gaap_DepreciationNonproduction 231,853us-gaap_DepreciationNonproduction
Amortization expense   844,172us-gaap_AmortizationOfLeasedAsset 1,230,293us-gaap_AmortizationOfLeasedAsset
Disposal of lease monitoring equipment   209,757scra_DisposalOfLeaseMonitoringEquipment 296,526scra_DisposalOfLeaseMonitoringEquipment
Research and development expenses   1,605,662us-gaap_ResearchAndDevelopmentExpense 987,934us-gaap_ResearchAndDevelopmentExpense
Advertising costs   60,505us-gaap_AdvertisingExpense 30,782us-gaap_AdvertisingExpense
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   347,251us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 604,006us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Revenue [Member] | Customer B [Member]      
Revenue 387,483us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CustomerBMember
1,501,940us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CustomerBMember
1,622,327us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CustomerBMember
Revenue [Member] | Customer C [Member]      
Revenue 518,137us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CustomerCMember
1,431,854us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CustomerCMember
1,514,581us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CustomerCMember
Revenue [Member] | All Concentration Risk Customers [Member]      
Revenue $ 905,620us-gaap_Revenues
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= scra_CocentrationRiskAllCustomersMember